PDPitra Ariesta Shinta Dewi

Pitra Ariesta Shinta Dewi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pitra Ariesta Shinta Dewi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Aroem Naroeni

    Univ Indonesia, Dr Cipto Mangunkusumo Gen Hosp, Fac Med, Stem Cell Med Technol Integrated Serv Unit, Jakarta, Indonesia

    2 shared publications
  • Ratna Sitompul

    Univ Indonesia, Fac Med, Dept Ophthalmol, Jakarta, Indonesia

    2 shared publications
  • Jeanne Adiwinata Pawitan

    Univ Indonesia, Fac Med, Dept Histol, Jakarta, Indonesia

    1 shared publication
  • Jeanne Pawitan

    Department of Histology, Faculty of Medicine, University of Indonesia, Jakarta

    1 shared publication
  • Radiana Dewayani Antarianto

    Univ Indonesia, Fac Med, Dept Histol, Jakarta, Indonesia

    1 shared publication

Latest Publications

  • Open Access

    Improvement of Corneal Nerve Regeneration in Diabetic Rats Using Wharton's Jelly-Derived Mesenchymal Stem Cells and their Conditioned Medium

    by Pitra Ariesta Shinta Dewi, Ratna Sitompul, Jeanne Adiwinata Pawitan, Aroem Naroeni, Radiana Dewayani Antarianto

    To investigate the efficacy of Wharton's jelly mesenchymal stem cells (WJSCs) and their conditioned medium (CM) for corneal nerve regeneration in rats with diabetic keratopathy. Streptozotocin (STZ)-induced male diabetic (DM) rats (250-300 g) were divided into four groups (n=7/group): Control, DM, DM with WJSCs (DM+WJ), and DM with CM treatment (DM+CM). DM+WJ and DM+CM group received WJSCs or CM, respectively, topically with eye drops. Corneal sensibility, corneal epithelial layer integrity, histology, expression of GAP-43 and TUBB3 on mRNA level and their immunohistochemical expression were examined after two weeks of treatment. There were changes in corneal sensibility and corneal integrity between normal control and diabetic groups with/without WJSC or CM injection. Total central corneal thickness was significantly higher in DM+CM (249.81 & PLUSMN; 43.85 & mu;m) than in control (174.72 & PLUSMN; 44.12 & mu;m, P=0.004) and DM groups (190.15 & PLUSMN; 9.63 & mu;m, P=0.03). GAP-43 mRNA expression levels of DM+WJ and DM+CM groups were higher compared with DM and control groups. TUBB3 mRNA level was increased after CM (P=0.047), but not after WJSCs treatment (P=1.00). GAP-43 and TUBB3 immunohistochemical expression of nerve fibers along the epithelial layer significantly increased in DM+WJ and DM+CM compared with DM group. Our findings showed that WJSCs and their CM improved corneal nerve regeneration in rats with diabetic keratopathy.


  • Open Access

    Animal model of diabetic keratopathy

    by Pitra Ariesta Shinta Dewi, Ratna Sitompul, Jeanne Pawitan, Aroem Naroeni

    Diabetic keratopathy is one of the most common ocular complications in diabetes mellitus. Protocol for diabetes induction in rat model also has been established in many centers. Nonetheless, method in developing diabetic keratopathy rat model has not been well covered. Streptozotocin (STZ) -induced diabetes is widely being used as animal diabetic model. The purpose of this study is to obtain an animal model of diabetic keratopathy that can be used to study the morphology, metabolism, and function of cornea in cases where human samples can be difficult to obtain. A single dose STZ (50 mg/kg) was injected intraperitoneally to control and intervention group. Plasma glucose level concentrations were tested in day 3 postinjections. Obtained animal model of diabetic keratopathy, with significant difference of blood glucose level between intervention and control group (P<0.00). Sensibility of cornea was decreased by week 14th in intervention group. Epithelial defect were more prominent in diabetic group. Despite the differences between human and animal characteristic of diabetic keratopathy, the use of animal models has contributed to better understanding of this disease and to examine more effective treatment.